Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Japan Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20054
20065
20073
20083
20092
20103
20111
20122
20131
20142
20154
20174
20203
20212
20247
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Active, not recruiting7
Recruiting7
Terminated7
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Pfizer5
AstraZeneca3
Bayer3
GlaxoSmithKline3
Daiichi Sankyo2
Eli Lilly and Company2
Japan Breast Cancer Research Group2
Japan Breast Cancer Research Network2
Nagoya City University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms54
Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Triple Negative Breast Neoplasms4
Biliary Tract Neoplasms3
Esophageal Neoplasms3
Head and Neck Neoplasms3
Melanoma3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.